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ABSTRACT 
 
The exact aetiology of periodontitis is unknown but it is believed to result from an 
infection by a select group of Gram-negative anaerobic bacteria found in dental 
plaque. However in order for the periodontal pocket to be populated by these 
suspected periodontopathogens, they require that the local environment be primed 
for their colonization. This favourable environment results from a series of 
progressive colonizations by prior groups of bacteria, the process being termed 
bacterial succession. Essential to bacterial succession is the initial colonization of the 
tooth surface by bacteria termed “the primary plaque colonizers”. These are 
assumed to be the first species in biofilm formation. Elimination of these species 
might therefore be beneficial to prevent bacterial succession and later colonization 
by the suspected periodontopathogens. Aim: To determine whether there was any 
significant difference in the antimicrobial activity of 4 herbal toothpastes against 
cultures of 3 primary plaque colonizers (Streptococcus mutans, Streptococcus 
sanguinis and a non-specific α-heamolytic streptococcus). Method: The study was a 
laboratory based experiment that used in-vitro diffusion to assess the antimicrobial 
potential of the various toothpastes. Forty eight cultures were produced and grown 
overnight in a temperature controlled room. The various zones of inhibition formed 
around the test toothpastes were then measured after 24hrs of incubation and 
compared to each other. Results: Of the four toothpastes tested, Dentazyme 
Herbal® showed the greatest ability to inhibit bacterial growth.  It was stronger than 
Colgate Total®   (the positive control) for 2 of the 3 species of bacteria tested. Nature 
Fresh® had the lowest potential for antimicrobial activity and only displayed a 
moderated inhibitory affect for one of the bacterial species tested. Conclusion: The 
results indicate that there was a significant difference in the ability of the various 
toothpastes to inhibit the growth of certain bacteria.   
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CHAPTER 1 
INTRODUCTION 
 
Periodontal disease is one of the most common causes of tooth loss. It is a condition 
that affects a considerable portion of the population (Beck and Arbes 2002) and 
clinically presents in a variety of forms. Although adults make up the majority of 
those affected, it can and does affect children appearing as either a slowly 
progressive or, rarely, a rapidly destructive disorder.  
 
The exact aetiology of periodontitis is unknown but it is believed to result from an 
infection by a select group of Gram-negative anaerobic bacteria found in dental 
plaque. These include Actinomyces actinomycetemcomitans, Porphyromonas 
gingivalis, Treponema denticola, and Tannerella forsythia (Lovegrove 2004; Inagaki 
et al, 2006). However in order for the periodontal pocket to be populated by these 
suspected periodontopathogens, they require that the local environment be primed 
for their colonization. This favourable environment results from a series of 
progressive colonizations by prior groups of bacteria, the process being termed 
“bacterial succession”.  
 
Essential to bacterial succession is the initial colonization of the tooth surface by 
bacteria termed “the primary plaque colonizers”. These include several species of 
Streptococci and Actinomyces. These are assumed to be the first species in plaque 
biofilm formation. Elimination of these species might therefore be beneficial in 
preventing bacterial succession and later colonization by the suspected 
periodontopathogens.  
 
Because of the infectious nature of the condition, treatment has always been 
directed towards the reduction or elimination of the suspected periodontopathogens 
(van Winkelhoff et al 2002; Preshaw et al 2004).   
 
Mechanical and surgical debridement has been used as the mainstay of disease 
management. This approach has never been completely successful and in the past 
decade, antibiotics and other antimicrobial agents have been used to supplement 
conventional treatment (Cosyn and Wyn 2006; Greenstein 2006). Antibiotics are 
used both locally and systemically and both methods are known to significantly 
influence the microflora associated with periodontally diseased sites.   
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In order to increase the effectiveness of plaque removal, antimicrobials have been 
added to toothpastes. The most effective of these being triclosan. It is a chemical 
that has a wide range of antimicrobial activity and when tested clinically, it improves 
the condition of patients suffering form gingivitis and periodontitis (Cullinan et al 
2003). Although it has been touted as a promising agent in the management of 
periodontal disease, it has recently been shown that triclosan-resistance is starting to 
emerge. Because of this, the widespread incorporation of triclosan into everyday 
products may eventually pose a potential public health risk (Yazdankhah et al 2006).    
 
In an attempt to find better and more potent antimicrobials, plant and herbal based 
products have been tested for their potential therapeutic effects (Arora and Kaur 
1999; Lai and Roy 2004; Natarajan et al 2003; O’Hara et al 1998). A number of 
these agents are effective against oral pathogens and manufacturers have now 
incorporated them into toothpastes (Wu-Yuan et al 1990; Kaim et al 1998; Groppo et 
al 2002; Lee et al 2004; Uzel et al 2005).These anti-microbial properties may 
therefore have some therapeutic benefit to patients suffering from periodontal 
disease.  
 
The elimination or reduction of the “primary plaque colonizers” might potentially 
inhibit the growth of the plaque biofilm and thereby prevent subsequent colonization 
by the suspected periodontopathogens.  This study attempts to investigate the anti-
microbial efficacy of four over-the-counter herbal-based toothpastes against specific 
species of three primary plaque colonizers (Streptococcus mutans, Streptococcus 
sanguis and a non specific α-heamolyitic streptococcus termed VS-1).   
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1. INTRODUCTION 
 
Periodontal disease encompasses a broad spectrum of pathological disorders that 
affects the supporting structures of the dentition. Clinically it is either limited to 
inflammation of the soft tissue surrounding the tooth, but it can also appear as a 
destructive disorder of the alveolar bone and periodontal ligament.   
 
The two most common clinical manifestations of periodontal disease are gingivitis 
(limited to the gingiva) and periodontitis (involving both the gingiva as well as the 
periodontal attachment apparatus), both of which are thought to be bacteria related. 
Gingivitis is commonly controlled with plaque inhibitory measures whereas 
periodontitis often requires more aggressive treatment options.  The uncontrolled 
progression of periodontitis leads to increased tooth mobility and eventual tooth loss. 
Recently periodontitis has been linked to systemic conditions such as low preterm 
birth-weight and cardiovascular disease (Beck and Offenbacher 2001; Yeo et al 
2005)  
 
The management of periodontitis is not universal or standardized and consequently 
many treatment options exist. The antimicrobial properties of herbs are well 
established and their potential clinical benefit in the management of periodontal 
disease should therefore be explored.      
 
This literature review explores the aetiology and pathogeneses of periodontal 
disease with specific reference to its associated microbiology and the attempts to 
manage it using antimicrobial agents. 
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2.2.  PERIODONTITIS 
 
Periodontitis is defined as an inflammatory disease of the periodontium that extends 
beyond the gingival margin. It results in the progressive destruction of the 
periodontal ligament and alveolar bone, and may be associated with gingival 
recession (Beck and Arbes 2002).   
 
The prevalence of the disease is difficult to quantify because no uniform criteria for 
periodontal research has been established (Borrell and Papapanou 2005; 
Papapanou and Lindhe 2003). This is further compounded by the fact that the 
disease classification has repeatedly been revised resulting in different studies using 
different research criteria (Borrell and Papapanou 2005). As a result, inconsistent 
data has been produced. This is due mainly to variations in the threshold values 
used to define the disease (Borrell and Papapanou 2005; Papapanou and Lindhe 
2003).         
 
An international workshop was held in 1999 in order to address these contentious 
issues. The sole purpose of this workshop was to reach consensus on the 
classification of periodontal diseases and conditions. This workshop, known as the 
“1999 Workshop for a Classification of Periodontal disease and Conditions” was 
arranged by the American Academy of Periodontology and included experts from 
around the world. This meeting lead to the current classification of periodontal- 
related-diseases (Armitage 2004). Eight major categories of periodontal diseases 
were listed. These eight categories are as follows (Milward and Chapple 2003): 
 
I. Gingivitis 
II. Chronic periodontitis 
III. Aggressive periodontitis  
IV. Periodontitis as a manifestation of systemic diseases 
V. Necrotizing periodontal diseases 
VI. Abcesses of the periodontium 
VII. Periodontitis associated with endodontic lesions 
VIII. Developmental or acquired deformities and conditions.  
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One of the most significant changes to the previous classification was the 
discontinuation of terms related to age of presentation and rate of progression of the 
disease. It was felt that these criteria were ambiguous since it is often impossible to 
determine when periodontal disease starts or how fast it progresses if previous 
dental records are not available. The fact that disease progression can either be 
slow and constant or episodic, and the finding that similar disease presentations are 
found at most ages, provided additional evidence for removing certain terms (Wiebe 
and Putnins 2000). 
 
2.3.  CLINICAL FEATURES OF PERIODONTITIS  
 
Based on the 1999 classification, periodontitis may present as one of three major 
clinical forms i.e. chronic, aggressive and necrotizing. All are associated with 
pathological alveolar bone loss.    
 
Chronic periodontitis is a slowly progressive disease that is characterized by gingival 
inflammation, bleeding on probing, reduced resistance of the pocket periodontal 
tissues to probing, loss of clinical attachment and the loss of alveolar bone (Kinane 
and Lindhe 2003). It may involve both the primary and secondary dentition and can 
affect any age. However it is most prevalent in adults. (Consensus Report 1999). 
The condition is subdivided into localized and generalized types depending on the 
number of sites affected. Localized being up to 30% of the sites, and generalized 
being more than 30% of sites (Milward and Chapple, 2003). Chronic periodontitis 
has the following features: 
 
• The amount of destruction of the periodontium is consistent with the presence 
of local risk factors 
• Subgingival calculus being a frequent finding 
• Slow to moderate rate of progression 
• Modified by systemic disease 
• Modified by other factors such as smoking or stress 
 
The severity of the disease can be described for the entire dentition or for individual 
tooth or sites. 
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Aggressive periodontitis comprises a group of rare, severe, rapidly progressive forms 
of periodontitis often characterized by an early age of onset (less than 30 years old) 
and a distinctive tendency for cases to aggregate in families. It can occur in both the 
primary and permanent dentition and is clinically associated with a systemically 
healthy patient that displays rapid loss of alveolar bone and clinical attachment 
(Milward and Chapple 2003).  
 
Like chronic periodontitis, aggressive periodontitis is subdivided into localized or 
generalized conditions, each with its own clinical features. Localized aggressive 
periodontitis is associated with the onset around puberty and commonly involves the 
first molar and incisor. There is often an associated elevated serum response to 
serum antibody.  Generalized aggressive periodontitis often affects people under the 
age of 30 years but can be found in older patients. Its diagnosis is based on the 
involvement of at least three permanent teeth other than first molars and incisors.  
Another important feature of this condition is the pronounced and episodic loss of 
clinical attachment and alveolar bone.  This characteristic pattern of bone loss is 
thought to be common to most forms of periodontitis and is consistant Socranky’s 
proposed “Burst Theory”.  In this hypothesis, Socransky et al (1984) suggests that 
periodontal destruction occurs in periodic short episodes and not in a time 
dependant manner.   
 
Necrotizing periodontal disease is the most severe destructive periodontal disorder 
caused by plaque bacteria (Holmstrup and Westergaard 2003). It is more prevalent 
amongst children of developing countries and is often seen in the 
immunocompromised. The condition is acute and the lesions are characterized by 
rapid attachment loss and open gingival craters. The clinical course of the disease is 
characterized by intervening periods of acute ulceration. The diagnosis is usually 
made clinically and the management involves local debridement and supplementary 
systemic antibiotics.  
 
2.4.  THE AETIOLOGY AND PATHOGENESIS OF PERIODONTAL DISEASE 
 
The exact aetiology of periodontal disease is not known but periodontitis and 
gingivitis appear to be a continuum of the same inflammatory process (Kinane and 
Attstrom 2005). Most authors regard a consortium of bacteria (and not a single 
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species) located within subgingival plaque as the main contributing factor to 
periodontal destruction (Kilian et al 2006; Sanz et al 2005; Haffajee and Socransky 
2005; Kinane and Attstrom 2005). Others consider the biological structure of plaque 
(i.e. a biofilm), as a more significant factor than individual bacterial species (Marsh 
2005). Recently, DNA studies have recognized more than 700 different species of 
bacteria located in subgingival plaque (Kilian et al 2006). Less than half of these 
have been cultured. Consequently a major limitation exists in our current 
understanding of the aetiology of the condition.  
 
Animal and epidemiological studies have associated certain species of bacteria with 
periodontal disease. In 1996, “The World Workshop in Periodontology” identified 
several of these organisms and classified them as periodontal pathogens. They 
include a select group of Gram-negative anaerobic bacteria such as Actinobacillus 
actinomycetemcomitans, Porphyromonas gingivalis, Treponema denticola, and 
Tannerella forsythia (previously known as Bacteroides forsythus) (Lovegrove 2004; 
Inagaki et al 2006).These and other bacteria were implicated, based on their 
detection by culture and molecular methods, their proportions in plaque, associated 
immunological responses and the fact that they possess biochemical properties 
consistent with pathogenicity (Curtis et al 2005). They appear in higher numbers in 
patients with periodontal disease and have rarely been isolated from healthy 
subjects (Teanpaisan et al 1995; van Winkelhoff et al 2002; Lovegrove 2004). Even 
though these bacteria have consistently been found in periodontal diseased sites, 
not everyone harbouring these organisms develops periodontal disease (Cullinan et 
al 2003).  Therefore, the question of whether the presence of specific 
microorganisms may be the cause or the consequence of disease, remains 
unanswered (Socransky et al 1997) 
 
2.5. HOST-MICROBIAL INTERACTION 
 
According to Offenbacher (1996), bacterial and endotoxic exposure are not sufficient 
enough to cause periodontal disease. It is therefore postulated that a major 
component of both hard and soft tissue destruction is immune modulated (Berglundh 
and Donati 2005; Salvi and Lang 2005, Madianos 2005).  
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According to Salvi and Lang (2005), host-mediated tissue destruction is 
characterized by the expression of endothelial cell and intercellular adhesion 
molecules together with the production of host-derived inflammatory mediators. 
These mediators, although meant to protect the host against bacterial infections, are 
non-specific, and many of the known bacteria associated with periodontal disease 
have developed mechanisms that protect themselves against them. Failure of the 
host to eliminate the offending organism results in the adaptive immune response 
being activated. This is a more specific mechanism of targeting the infectious agent 
in an attempt to remove the offending organism.  It is characterized by the release of 
a number of specific inflammatory mediators that include cytokines such as 
interleukin-1 (IL-1) and tumour necrosis factor (TNF)-α. Both of these have been 
implicated in tissue destruction and bone resorption and are found in high 
concentrations in diseased periodontal tissues (Shapira et al 2005). These and the 
other cytokines stimulate the uncontrolled production of further mediators that 
accelerate the inflammatory process and further contribute to the progression of the 
disease.  
 
Berglundh and Donati (2005) completed a systematic review of the host response in 
periodontal.  From their literature search, it was shown that irrespective of whether 
periodontitis was chronic or aggressive, the cellular composition was similar. B cells 
were always found in higher numbers in diseased sites. It was concluded that 
sufficient evidence exists to suggest that an autoimmune component might play a 
significant role in the pathogenesis of periodontitis.  
 
Several risk factors for periodontal disease have been identified. These include 
smoking, diabetes mellitus and stress. Recently, genetic variability has also been 
studied as a possible risk factor. This is because genetic variation may influence the 
hosts’ inflammatory process and therefore the susceptibility to disease. However 
according to Shapira et al (2005), there is no evidence for a direct interaction 
between genetic polymorphism and inflammatory responses in periodontal tissues. 
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2.6. THE PERIODONTITIS ASSOCIATED BACTERIAL COMPLEXES 
 
In 1998, Socransky and colleagues identified five sets of bacteria that were 
repeatedly found together in periodontitis.  These bacterial complexes were defined 
based on the analysis of the microbial profiles of over 13,000 plaque samples taken 
from 185 subjects using DNA probes in checkerboard hybridization assays. They 
divided the microbiota into groups that appeared to occur together in biofilms of 
gingival health, gingivitis or periodontitis. These groups of bacteria were categorized 
and colour coded depending on their sequence of developing on the tooth surface as 
well as their association with disease severity. The resultant groups/complexes 
included the yellow, green, purple, orange and red complexes. The constituents of 
the various complexes are listed in Table 1. 
 
The red complex appears late in bacterial colonization of the periodontal pocket. The 
appearance of these organisms are preceded by a complex of somewhat less 
virulent bacteria called the orange complex. The red complex is significant because it 
represents a portion of the climax community in the biofilm of sites associated with 
progressing periodontitis. It is thought to be associated with active disease sites and 
its appearance correlates with the development of clinical signs associated with 
periodontal disease. Holt and Ebersole (2005) studied the virulence factors 
associated with the red complex and suggested that P. gingivalis benefits from a 
nutritional interdependence with T. denticola.  Both these bacteria posses several 
factors that allow them to be significant in the pathogenesis of periodontal disease. 
These include; 
 
• they occur concomitantly with clinical signs of periodontal destruction, 
• they appear closely linked topologically in the developing biofilm 
• they produce a number of outer membrane proteases 
 
How these complexes, as well as how the virulence factors of the individual bacteria 
contribute to disease progression, remains unclear.  However, P. gingivalis has 
consistently been found in higher numbers in patients suffering form periodontal 
disease. The bacterium also possesses unique factors that contribute to host tissue 
destruction and its presence is common in patients who are resistant to conventional 
treatment.  
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Purple 
 
Actinomyces odontolyticus 
Veillonella parvula 
 
 
Yellow 
 
 
Streptococcus  gordonii 
Streptococcus  intermedius 
Streptococcus mitis 
Streptococcus oralis 
Streptococcus sanguis 
 
 
Green 
 
 
Actinomyces actinomycetemcomitans 
Capnocytophaga gingivalis 
Capnocytophaga ochracea 
Capnocytophaga sputigena 
Eikeinella corrodens 
 
 
Orange 
 
 
Campylobacter gracilis 
Campylobacter rectus 
Campylobacter showae 
Eubactrium nodatum 
Fusobactrium nucleatum ss polymorphum 
Fusobacterium nucleatum ss vincentii 
Fusobactrium periodonticum 
Peptostreptococcus micros 
Prevotella intermedia 
Prevotella nigrescens 
Streptococcus constellatus 
 
 
Red 
 
Tannerella forsythia 
Porphyromonis gingivalis 
Treponema denticola 
 
 
Table 1: Bacterial Complexes associated with Periodontal Disease (Socransky 
and  Haffajee 2005) 
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2.7. P. Gingivalis AS A PERIODONTOPATHOGEN 
  
P. gingivalis is a Gram-negative, anaerobic, non-motile asacchrolytic rod that is 
commonly found in the biofilm of subgingival plaque associated with periodontal 
disease. It is a highly virulent organism that is resistant to complement killing and it is 
often associated with recurrent or persistent periodontal disease.  It was identified as 
a periodontopathogen in 1999 and has been associated with the red complex 
(Socransky et al 1998). Several serotypes of the organism exist. This is based on 
whether antisera binds to its capsule, fimbria or outer membrane antigens (Table 2).  
 
 
Strain Capsular serotype Fimbrial
Serotype 
Outer 
membrane 
serotype 
    
W50 K1 V C 
W83 K1 V C 
HG184 K2 _ _ 
A7A1-28(ATCC 52977) K3 II B 
ATCC 49417 K4 II _ 
HG1690 K5 _ _ 
HG1691 K6 _ _ 
381 K-neg I AD 
2561 (ATCC 33277) K-neg I A 
FAY19m-1 _ III _ 
9-14K1 _ _ _ 
 
Table 2: Serotypes of P. gingivalis (O’Brien Simpson et al 2004) 
 
P. gingivalis has several features that allows it to cause tissue destruction. Holt and 
Ebersole (2005) listed several of these features which included the production of a 
variety of cell-surface associated proteolytic enzymes, toxins and hemolysins. These 
play a significant role in the spread of the organism through tissue and in the evasion 
of the host defences. 
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More specifically, the ability of the organism to be an effective periodontopathogen is 
due to the following identified characteristics; 
 
• The ability of the bacteria to adhere to various host structures.  
 
The binding capacity of P. gingivalis is a key feature of its virulence. It 
contributes to the initial attachment of the organism and is important to the 
coaggregation of multiple species of bacteria within the plaque biofilm. Long, 
thin, multimetric protein structures known as fimbriae make this binding 
process possible (Madianos et al 2005).  These hair-like appendages cover 
the outer membrane of most strains of P. gingivalis and bind to a variety of 
structures such as epithelial cells, fibroblasts, extracellular matrix proteins and 
other bacteria. The binding capacity is due to the fact that they stimulate 
signal transduction and induce cytoskeletal remodeling within cells (Nishihara 
and Koseki 2004). Besides contributing to co-aggregation, fimbria also allows 
the bacteria to invade and multiply in host tissues. 
 
P. gingivalis fimbriae are highly antigenic, resulting in high serum IgA and IgG 
antibody responses in both chronic and aggressive periodontitis (O’ Brien 
Simpson et al 2004). The remodelling associated with adhesion also results in 
the expression of cell surface adhesion molecules which induces the 
recruitment of leukocytes and other inflammatory mediators to the site 
(Madianos 2005). These include bone resorbing factors such as interleukin-1α 
(IL-1α), interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α).    
 
• The P. gingivalis capsule 
 
A 15nm-thick polysaccharide heteropolymer capsule surrounds the outer 
membrane of the majority of strains of P. gingivalis (O, Brien Simpson et al 
2005). It is a potent antigen and has the ability to induce a highly invasive 
spreading ulceration. It provides physical protection to the organism by 
making it resistant to phagocytosis and the alternative compliment pathway. 
Long-term exposure to the capsular polysaccharide alters the root surface of 
the tooth and prevents fibroblast attachment. This may explain why the 
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bacterium persists in lesions after conventional treatment has been carried 
out.  
 
• The ability to produce proteases.  
 
P. gingivalis produces a number of proteases that degrade host proteins and 
modulate the host immune response.  These macromolecules are non-
specific enzymes that contribute nutrients that are necessary for bacterial 
growth (Holt and Ebersole 2005). They cause collateral damage by 
degenerating types I and IV collagen (both of which are major components of 
the periodontal connective tissue) as well as extracellular matrix proteins (e.g. 
fibrinogen and laminin).   
 
Arginine-gingipain (Rgp) and Lysine-gingipain (Kgp) are trypsin-like proteases 
that form part of the cysteine protease family. These “gingipains” are found on 
the outer surface of the organism and are unique in that they have very little 
structural resemblance to similar studied proteins. As a result they have been 
classified into a separate protein family i.e. C25 of the cysteine proteases. 
They are responsible for the release of a large variety of pro-inflammatory 
factors, including interleukin-six (IL-6), a known bone-resorbing molecule. 
Arginine-gingipan in particular, induces Ca+2 release from infected cells which 
results in an increased production of IL-6.   
   
• The production of lipopolysaccharide 
 
The outer membrane of P. gingivalis is made up of lipolysaccharides (LPS). 
These are amphiphatic molecules that are structurally divided into three parts 
i.e. the O-polysaccharide (or O-antigen), the core polysaccharide and the lipid 
A (Madianos et al 2005). It induces alveolar bone destruction by stimulating 
the release of a number of pro-inflammatory cytokines. These include 
interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interferon-γ 
(INF-γ), IL-12, IFN inducible protein-10 (IP-10) and tumour necrosis factor-α 
(TNF-α)   (Holt and Ebersole 2005). Because of this osseodestructive 
property, it is suggested that in combination with nicotine from smoking, a 
known risk factor for periodontitis, there is an increased risk for the 
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potentiation of periodontal disease. Recently it has also been found that LPS 
induces apoptosis of host cells (Holt and Ebersole 2005). 
      
• The production of GroEL heat shock protein 
 
A number of bacteria respond to environmental stresses by synthesizing 
specific stress proteins, including heat shock proteins. The P.gingivalis GroEL 
heat shock protein is highly antigenic and a number of antibodies directed 
against this protein has been detected in gingival extracts (O, Brien Simpson 
et al 2004). This protein cross-reacts with heat shock protein 60 (hsp60) and 
this is thought to induce an autoimmune reaction that is essential in the 
pathogenesis of arthrosclerosis (Hajishengallis et al 2002). However these 
cross-reactions are non-specific and inconsistent and further research is 
required to confirm this hypothesis.  
 
P. gingivalis therefore demonstrates multiple components, particularly its cysteine 
proteases (i.e. gingipains) that alter host cell and tissue functions. This composite of 
adaptive capabilities make the microorganism a significant component of the climax 
biofilm linked to periodontal tissue destruction. Data from human epidemiologic 
studies suggests that P. gingivalis may accomplish triggering of disease processes 
more effectively in conjunction with a microbial consortium of T. denticola and T. 
forsythia. 
 
2.8.  PLAQUE BIOFILM AND THE ROLE OF THE “INITIAL PLAQUE COLONIZERS” IN 
THE DEVELOPMENT OF PERIODONTAL DISEASE 
 
Although certain bacteria have been associated with periodontal disease, their role 
as the sole aetiological agent in the development of the condition has not been 
established (Marsh 2005).   Whether these bacteria are the cause, or are secondary 
invaders subsequent to the development of periodontal disease, is difficult to 
determine.  
 
The so-called “periodontopathic” bacteria require specific conditions that favour their 
growth. These conditions are primed for by other bacteria (known as the early or 
primary colonizers) that occupy the area prior to the growth of the 
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periodontopathogens. This process of bacterial colonization is known as “bacterial 
succession” and is an essential component of plaque formation.  
 
The consequence of this sequential bacterial colonization is the formation of a biofilm 
that has pathogenic properties which are greater than the sum of its individual 
components. Because of this, several authors have favoured the hypothesis that 
biofilm formation and not individual bacterial species, cause periodontal disease 
(Marsh 2005). 
 
The primary plaque colonizers are essential to plaque formation. This process 
consists of four distinct stages (Lang et al 2003): 
 
• Phase 1 (Molecular adsorption) 
• Phase 2 (Bacterial adhesion) 
• Phase 3 (Growth of extracellular matrix production and multiplication of 
adhering bacteria) 
• Phase 4 (Sequential adsorption of further bacteria to form a more complex 
and mature biofilm) 
 
Primary colonization which is the second stage of plaque formation is characterized 
by bacterial attachment. The bacteria that participate in this process are derived 
mostly from the Viridans / indifferent group of streptococci which encompass many 
inconsistent features. They typically inhabit the oropharynx, forming up to 25% of the 
total cultivable flora and are transmitted via mother to child.  Four main groups exist 
(Samaranayake 1999): 
 
1. Streptococcus mutans (S. mutans) 
2. Streptococcus salivarius (S. salivarius) 
3. Streptococcus milleri (S. milleri) 
4. Streptococcus oralis (S. oralis) 
 
These bacteria have unique characteristics that determine the maturation of dental 
plaque. They use oxygen and lower the reduction-oxygen potential of the 
environment, which then favours the growth of the more virulent anaerobic species. 
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Many of the primary colonizers also have the ability to directly modify the 
characteristics of the local environment.  One such species is S. mutans.  
 
S. mutans, which is a major aetiological agent in the development of dental caries, 
has the ability to induce altered gene expression and in so doing, up or down 
regulate the production of certain proteins (Marsh 2005). This results in an increase 
in the amount of enzymes available for carbohydrate metabolism as well as the 
amount of adhesins necessary for subsequent bacterial attachment. This directly 
affects the ability of subsequent bacteria to colonize the area.  
 
S. mutans also plays an important protective role in biofilm formation. This is 
characterized by the production of certain proteins, including competence stimulating 
peptide (CSP). CSP is a specialized protein that’s release is stimulated by a local 
drop in pH. Upon release from the bacteria, it permeates the surrounding area, 
thereby not only offering protection to the bacterium that has released it, but also to 
the neighbouring cells.  
 
S. sanguinis, another viridans type streptococcus, is the most prominent organism 
retrieved from 24 hr old dental plaque. It is a major primary plaque colonizer and has 
the ability to bind to host tissue. This is likely to play a critical step in bacterial 
invasion (Haake et al 2002). Its binding ability is not only limited to epithelial cells but 
also allows the bacteria to interact with other colonizing species. This bacterial 
interaction results in the co-aggregation of a number of different species thereby 
altering the structure and properties of the plaque biofilm. These types of interactions 
are thought to be of primary importance in the progressive colonization of the 
periodontal environment (Haake et al 2002). The interactions is that formed between 
Streptococcus sanguinis and Actinomyces vicosus is most well known example of 
this.  
 
The viridans type streptococci therefore play a significant role in the development of 
the dental plaque. They are the initial colonizers of a process that potentially leads to 
the development of a biofilm of pathogenic osseodestructive bacteria. It is therefore 
logical to hypothesize that removal or reduction of the primary plaque colonizers 
would result in failure or inhibition of a pathogenic biofilm formation.  This might have 
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potential therapeutic applications for the prevention or management of periodontal 
disease. 
 
2.9. THE MANAGEMENT OF PERIODONTAL DISEASE 
 
The treatment of the infectious component of periodontal disease, and the 
replacement of damaged or lost periodontal tissues are achieved using different 
approaches. Mechanical therapies, such as scaling, root planing and surgery, are 
aimed at improving the clinical condition by effectively lowering the microbial load 
(and therefore affecting the bioflim) either by physically removing the plaque or by 
radically altering the subgingival habitat. Antimicrobial approaches that use 
systemically and locally administered antibiotics target subgingival species residing 
in the plaque biofilm as well as those species that reside in the adjacent epithelial 
tissues lining the periodontal pocket.  
 
 
2.10. THE USE OF TOOTHPASTES IN THE MANAGEMENT OF PERIODONTAL 
DISEASE 
 
The ability of toothpaste to inhibit plaque formation with subsequent benefit to 
gingival health was realized more than 20 years ago with the introduction of 
chlohexidine as an oral antiseptic (Sheen et al 2001). Nevertheless most of the 
chemicals which have demonstrated plaque inhibition in laboratory studies, have not 
been incorporated into commercially available products. Those that are incorporated 
into toothpastes and mouthrinses include; 
 
• Cationic antiseptics such as chlorhexidine, hexeditine and cetyl pyrdimium 
chloride 
• Metal salts such as zinc citrate and stannous fluoride 
• Essential oils and phenolic derivatives 
• Enzymes 
• Herbal extracts 
 
Because of its substantivity, toothpastes provide an ideal mechanism for the delivery 
of an antimicrobial substance to the oral cavity. Certain toothpaste manufactures 
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have added antiseptics / antimicrobials to their products (Arweiler et al 2002). The 
most common of these agents is triclosan. It has been used since the 1960s in 
various medicinal products including topical antiseptics, soaps, hand washes and as 
therapeutic baths for methicillin-resistant-Staphylococcuss aureus patients.   
Triclosan is a non-ionic chemical that has a broad spectrum of antimicrobial activity. 
It is effective against a wide variety of Gram-negative and Gram-positive bacteria, 
mycobacteria, spores, strictly anaerobic bacteria and Candida (Sheen et al 2001). Its 
antibacterial mechanism of action is derived form the fact that it prevents amino acid 
uptake from the bacterial cytoplasmic membrane. As a result, membrane disruption 
occurs followed by leaking of the cellular contents and subsequent cell death (Sheen 
et al 2001). 
 
Triclosan also possesses anti-inflammatory properties (Sheen et al 2001).  This is 
due to its ability to inhibit the cycloxygenase/lipoxygenase pathway in arachadonic 
acid metabolism (Sheen et al 2001). 
 
The inclusion of triclosan into toothpastes has been studied extensively. When 
delivered in this way, the agent seems to bind to oral mucosal and tooth surfaces, 
and is particularly well retained in plaque (Sheen et al 2001).  In randomized clinical 
trials, triclosan based toothpaste was shown to reduce plaque associated with 
gingival inflammation (Muller 2006). When tested for its clinical benefits in the 
management of periodontitis, it was shown that the use of a triclosan/copolymer 
dentifrice was effective in slowing down the progression of periodontal disease 
(Cullinan et al 2003).  The Colgate formulation of triclosan and copolymer (Colgate 
Total®) has also been shown to reduce the onset of periodontitis in susceptible 
adolescents and to reduce the progression of periodontitis in previously “at risk” 
adults when compared to fluoride only toothpastes (Davies 2004). 
 
Metal salts such as zinc citrate have been added to toothpastes to enhance the 
antimicrobial activity of these antimicrobial agents (Davies 2004, Moron et al 2001).   
 
2.11. THE THERAPEUTIC EFFECT OF HERBS AND SPICES 
 
A herb can be defined as the leafy portion of a plant whereas any other part of the 
plant, often dried, is referred to as a spice (Hemphill and Cobiac 2006). Both have 
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been used for thousands of years for culinary use, medicinal purposes and 
preservatives (Hemphill and Cobiac 2006).  It is reported that the Sumerians were 
using thyme as far back as 5000BCE for its health properties (Hemphill and Cobiac 
2006). The Assyrians also developed knowledge about the health benefit of herbs, 
referring to the use of juniper, saffron and thyme around the time of 1000BCE.   The 
trend of using herbs for their therapeutic properties is currently still practiced and by 
1998 more than a third of Americans were using herbal based medication, spending 
up to $3.5 billion dollars annually on these products (Lee et al 2004).  
 
O’Hara (1998) reviewed 12 of the most commonly used medicinal herbs and showed 
that they had a wide range of pharmacological activity. Patch and Sullivan (2006) 
showed that garlic had a significant therapeutic effect on patients suffering from 
cardiovascular disease. From a meta-analysis level III evidence (Australian National 
Health and Medical Council levels of evidence) was presented showing that the 
consumption of a half to one clove of garlic (or its equivalent), had the ability to 
reduce cholesterol levels by up to 9%. It was also shown that garlic had a significant 
anti-clotting ability. 
 
There is no conclusive evidence indicating that herbs and spices have an 
anticarcinogenic effect in humans, however there is strong evidence from rodent 
studies that certain herbs and spices have a chemopreventative effect against the 
early initiating stages of cancer (Fenech 2006). Rosemary, basil, mint and lemon 
grass are known to have anticarcinogenic effects in animal models and tumeric has 
been shown to prevent cancers of the oral cavity, forestomach, liver and colon in 
mice (Fenech 2006). The cancer protective properties of these herbs are thought to 
be related to their potent anti-inflammatory qualities (Fenech 2006).   It is thought 
that the water soluble phenolic acids and falvinoids such as caffeic acid and 
quercetin are significant in this regard since they scavenge for reactive oxygen 
species that may lead to a state of oxidative stress (Fenech 2006).  This oxidative 
stress has been linked to an increased cancer risk.    
 
Herbs have been studied for their effect on mental health. The use of herbal 
treatments of anxiety is probably the most common example of a herbal influence on 
mental health.  Passiflora incarnate, or passion flower, has been approved for use as 
a sedative by the German Commission E (an expert committee commissioned by the 
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German Government in 1978 to evaluate herbal drugs and preparations from 
medicinal plants). Another herb Valeriana officianalis has also been shown to have a 
sedative effect in humans (Roodenrys 2006). A review of the potential chemical 
pathway for the action of Valeriana officianalis shows that it interacts with the GABA 
systems in the brain.  More recently there has been increased interest in the 
potential beneficial effects of the Chinese herb Ginkgo Biloba on cognitive 
processes. There exists level I evidence to support the claim that ginkgo can 
ameliorate cognitive decline in dementia and level II evidence exists showing that the 
herb can improve some aspects of memory function in human adults (Roodenrys 
2006). This cognitive nueroprotective effect is thought to be related to its antioxidant 
effect. Furthermore extracts from ginkgo are known to affect cerebral circulation, 
activity in the cholinergic system, and to have anti-oxidant properties.    
 
Herbs and spices also possess antimicrobial properties (Lai et al 2004; De et al 
1999; Arora and Kaur 1999; Harris et al 2001). Lai et al (2004) showed that 
commonly used herbs and spices such as garlic, black cumin, cloves, cinnamon, 
thyme, bay leaves and mustard all possess antimicrobial properties that may be 
used therapeutically. In certain studies the samples tested showed greater efficacy 
than synthetic antibiotics when tested against antibiotic resistant organisms (Arora 
and Kaur 1999). Others such as De et al (1999) and Kalemba and Kinicka (2003) 
have confirmed the antimicrobial properties of several of these plant based products.    
 
2.12. THE EFFECT OF HERBS ON ORAL PATHOGENS 
 
The antimicrobial effect of herbs and spices are well known and several researchers 
have tested their effectiveness against a variety of oral pathogens (Lee et al 2004; 
Kaim et al 1998; Koo et al 2000, Kagermeirer-Callaway et al 2000, Pistorius et al 
2003, Sastravaha et al 2003).  Eucalyptus leaf extract (Macrocarpals), and essential 
oils (derived from plants) such as manuka oil, tea tree oil, peppermint oil and sage oil 
have demonstrated significant antibacterial activity against periodontopathic and 
cariogenic bacteria (Nagata et al 2006, Takarada et al 2004). Tea tree oil in a 
concentration of greater than 0.5% has antimicrobial activity against a variety of oral 
bacteria including Actinomyces spp., Lactobacillus spp., Streptococcus mitis, 
Streptococcus sanguinis, Prevotella spp, Porphyromonas, Veillonella and 
Fusobacterium (Hammer et al 2003). In 2005, Filoche et al showed that there was  a 
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4 to 10 fold reduction in the amount of chlorhexidine used to inhibit a biofilm culture 
of Streptococcus mutans and Lactobacillus when it was combined with essential oils 
such as cinnamon, tea-tree (Melaleuca alternifola), manuka (Leptospermum 
scoparium), Leptospermum morrisonii, arnica, eucalyptus and  grapefruit.   
 
In 1998, Van der Weijden et al showed that a herbal mouthrinse containing various 
abstracts of juniper, nettle and yarrow, had antimicrobial activity against P. gingivalis.  
Bakri and Douglas (2005), tested the effectiveness of garlic (Allium sativum) against 
P. gingivalis and S. mutans. They showed that garlic extract killed most of the 
organisms tested and additionally had the ability to inhibit the trypsin-like and 
protease activity of  P.gingivalis by up to 94%.  
 
Propalis, a natural composite balsam produced by honey bees, has shown 
significant antimicrobial activity against a variety of bacteria, fungi and parasites 
(Gebara et al 2002).  When tested against several oral pathogens, Koo et al  (2000) 
showed that propalis had considerable antimicrobial activity against all the 
pathogens tested including Candida albicans. Gebara and colleagues (2002) also 
showed that propalis had significant antimicrobial activity against bacteria such as P. 
gingivalis, P. intermedia, P. melaninogenica, A.a, Capnocytophaga and F. 
nucleatum.   Feres et al (2005) tested the effectiveness of several herbs and plants 
against saliva obtained from patients with and without periodontal disease.  He 
concluded that propolis showed significant antimicrobial properties in samples from 
both periodontally healthy and diseased subjects and suggested that this substance 
may be used therapeutically in the future to inhibit oral microbial growth. 
 
Groppo et al (2002) compared the antimicrobial activity of tea tree oil, garlic, and 
chlorhexidine solutions against oral microorganisms and concluded that garlic and 
tea tree oil might be used as an alternative to chlorhexidine.  
 
2.13. HERBAL TOOTHPASTES 
 
Lee et al (2004) reviewed the anti-microbial activity of 14 herbal based toothpastes 
against certain oral pathogens. The majority of the products tested, displayed 
antimicrobial activity; however the study was only limited to 4 pathogens i.e. 
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Streptococcus mutans, Streptococcus sanguinis, Actinomyces vicosus and Candida 
albicans.  
 
Netuschil et al (2005) tested the efficacy of several toothpastes on plaque and 
gingivitis. Their study was conducted over a 6 month period, and Bleeding on 
Probing (BOP) was used as the endpoint. Significant reductions in both the plaque 
index and BOP were noted for Meliamint® (WALA Heilmittel, Bad Boll), a fluoride-free 
herbal based toothpaste that has peppermint, clove, chamomomile, mastic gum, 
propalis wax and chlorophyll as its main ingredients. When compared to Colgate 
Total® (Colgate-Palmolive, Hamburg), (a toothpaste that contains a known 
antmicrobial, triclosan), Meliamint® (WALA Heilmittel, Bad Boll), showed a 
consistently better reduction in the Gingival Index over the 6 month period (Netuschil 
et al 2005).   In a recent controlled clinical trial it was shown that a herbal toothpaste 
had the same clinical benefit effect as a conventional toothpaste containing triclosan 
and fluoride (Ozaki et al 2006). Herbal toothpastes have also been associated with 
side effects, the most common reported being plasma cell gingivitis (Anil 2007).        
 
Several herbal based dentifrices are now available in South Africa. Many are found 
in retail stores and are available without prescription.  Some of the herbs they 
contain include Myrrh, Sage, Eucalyptus, Tea tree oil, Mallow, Matricariae and 
Propalis and have the characteristics listed in Table 3. 
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                 Herb 
 
                           Indication 
 
Myrrh (Commiphora erythrae) 
 
Indicated as a topical treatment of mild inflammatory 
conditions of the mucous membranes, especially that of 
the mouth and throat 
 
Sage (Salviae trilobae folium) 
 
It is often indicated as an antiphlogistic as well as for 
inflammation of the mouth and throat 
 
Eucalyptus (Eucalyptus Globulus) 
 
The herb is  indicated for bronchitis and inflammation of 
the throat 
 
Tea Tree Oil (Melaleuca 
leucadendra)  
 
The oil possesses antibacterial, anti-inflammatory and 
anodyne properties. It is indicated for a number of 
conditions including; 
 
• Coryza 
• Influenza 
• Cough 
• Asthma 
• Toothache 
• Burns 
 
 
Matricariae (Matricariae recutita) 
 
It acts as a spasmolytic, antibacterial and antifungal. It 
is indicated for GIT complaints such as gastritis, enteriis 
and colitis. It is also used to manage inflammation of the 
mucous membranes of the mouth.    
 
Table 3: Herbs routinely used in herbal medicine (Bisset 2001) 
 
 
 
 
 
 
 24
CHAPTER 3 
AIMS AND OBJECTIVES 
 
3.1. AIM 
 
The aim of the study was to determine whether there was any significant difference 
in the antimicrobial activity of 4 locally available, herbal toothpastes against cultures 
of 3 specific primary plaque colonizers (Streptococcus mutans (NCTC 10920), 
Streptococcus sanguinis (NCTC 1940) and an α-heamolyitic streptococcus termed 
VS-1).  
 
3.2. OBJECTIVES OF THIS STUDY ARE: 
 
• To determine and compare the size of inhibition produced by different 
toothpastes against  Streptococcus mutans 
 
• To determine and compare the size of inhibition produced by different 
toothpastes against  Streptococcus sanguinis 
 
• To determine and compare the size of inhibition produced by different 
toothpastes against   VS-1 
 
3.3. NULL HYPOTHESES 
 
There is no significant difference in the antimicrobial activity of the four herbal 
toothpastes tested 
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CHAPTER 4 
MATERIALS AND METHODS 
 
4.1. STUDY DESIGN: 
 
This study was a laboratory based experiment that used in-vitro diffusion to assess 
the antimicrobial potential of various herb-containing toothpastes.  
 
4.2. SAMPLE SIZE 
 
A total of 48 cultures were produced. They were subdivided as follows;  
 
Fifteen standardized samples of each toothpaste were set up against each species 
of bacteria resulting in three distinct groups. This equates to a total of 45 test 
cultures. The three remaining cultures contained positive and negative controls for 
each of the three bacterial species. 
 
4.3. MATERIALS: 
 
1. TOOTHPASTES  
 
Four different over-the-counter, locally available herb-containing toothpastes, 
were used (Fig 1). These were purchased from a retail store in Cape Town, 
South Africa. Batch numbers and ingredients are listed as they appear on the 
container. They included: 
 
A) COLGATE HERBAL ®   100ML (COLGATE-PALMOLIVE COMPANY, SOUTH AFRICA).  
 
Batch number: 7035BR113F 
     
Active Ingredient: Sodium Monoflourophosphate 1.1% 
 
Ingredients: Aqua, Calcium Carbonate, Sorbitol, Sodium Lauryl Sulphate, 
Sodium Monoflourophosphate, Cellulose gum, Sodium silicate, Aroma, 
Sodium Bicarbonate, Sodium Saccharin, Eucalyptus Globulus Leaf Oil, 
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Xanthan Gum, Methylparaben, Commiphora Myrrh Extract, Chamomilla 
Recutita (Matricaria) Extract, Propylparaben, Metaleuca Alternifolia (Tea Tree) 
Leaf Oil, Salvia Officinalis (Sage) Oil, Eugenol, CI 74260 
  
B) NATURE FRESH HERBAL (ANTI-MICROBIAL) ®   100ML (NATURE FRESH,    
     CONSTANTIA, SOUTH AFRICA) 
 
Batch number: None stated 
 
Ingredients: Olive leaf, Aloe Ferox bitters, Cloves, Tea Tree, Mint and Aniseed 
oil with calcium, magnesium, sea salt, zinc and baking soda 
 
C) DENTAZYME HERBAL®   100ML (AMKA PRODUCTS, LONDON) 
 
Batch number: 326664  
 
Ingredients:  Sorbital, Hydrated Silica, Water (Aqua), Sodium Lauryl Sulphate, 
Peg-32, Flavour, Sodium Flouride, Cellulose Gum, Sodium saccharine, 
Methylparaben, Tea Tree (Melaleuca Alternifolia) leaf oil, CI 19140, CI 42090, 
Eugenol, Limonene, Linalool 
 
D) AQUAFRESH HERBAL ® 100ML (GLAXOSMITHKLINE, SOUTH AFRICA) 
 
Batch number: 667324  
 
Ingredients: Aqua, Hydrated Silica, Sorbitol, Glycerin, Peg-6, Sodium lauryl 
sulphate, Aroma, Carrageenan, Xanthan Gum, Sodium Flouride, Sodium 
Saccharin, Titanium Oxide, Eucalyptus Globulus, Mentha Arvensis, Salvia 
Officinalis, Anthemis nobilis, CI 77492, CI 74260, CI 73360  
 
E) COLGATE TOTAL ® 100ML (COLGATE-PALMOLIVE, SOUTH AFRICA) 
 
Batch number: 7145ZA10 
 
Active ingredients: Sodium fluoride 0.24%, Triclosan 0.3% 
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Ingredients: Aqua, Glycerin, Hydrated Silica, Sorbitol, PVM/MA Coplymer, 
Sodium Lauryl Sulphate, Flavour, Cellulose Gum, Sodium Hydroxide, Sodium 
Saccharin, Carrageenan (Chondrus Crispus), Sodium Flouride, Triclosan, 
Limonene, CI 77891 
 
         
 
             Fig 1:  Toothpastes used in the study 
 
 
2. MICROORGANISMS  
 
Three different groups of bacteria were used; 
 
• Streptococcus mutans (National Collection of Type Cultures, strain 
number 10920) 
 
• Streptococcus sanguinis (National Collection of Type Cultures, strain 
number 10904) 
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• A non specific α-heamolyitic viridans streptococci termed (VS1)*  
 
The bacteria used in this study were obtained from a standard culture stock that was 
stored at The Department of Medical Biosciences, University of the Western Cape. 
 
* - The “non specific α-heamolyitic viridans-type streptococci” used in this study is an   
      oral bacteria that has not officially been named yet. The term VS-1 was purely     
      used to distinguish it from the other species of bacteria in the study and is not  
      part of the official nomenclature         
 
3) CULTURE MEDIUM 
 
Columbia Blood Agar Base (CM0331) ® (Oxoid, UK) was used as the culture medium 
for all the bacterial species used in this study. This a multipurpose growth medium 
used for the cultivation of fastidious organisms (Website). It consists of special 
peptone 23.0gm/l, starch 1.0gm/l, sodium chloride 5.0gm/l, agar 10gm/l and has a  a 
pH of 7.3 ± 0.2.  
 
4) LABORATORY EQUIPMENT 
 
The following laboratory equipment were used (Fig 2): 
 
1. Forty-eight standard 90mm diameter sterile plastic Petri dishes 
 
2. Six standard sterile laboratory test tubes 
 
3. Ten standard McFarland turbidity tubes 
 
4. Sterile loop 
 
5. Sterile forceps 
 
6. Bunsen burner and lighter 
 
7. One hundred sterile 9mm antibiotic disks (Munktell, Germany) 
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8. One vortex mixer (Heidolph, Germany)  
 
9. One Pipetman®P calibrated pipette (Gilson, France) 
 
The study was carried out in The Department of Medical Biosciences, The University 
of Western Cape, Cape Town, South Africa, as per prior arrangement.  
 
 
 
 
 
        
Fig 2:  Laboratory equipment used in the study  
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4.4. METHODS 
 
The following sequence outlines the experiment that was conducted; 
 
1) PREPARATION OF AGAR PLATES 
 
• 39 Grams of the Columbia Blood Agar Base (CM0331) ® (Oxoid, UK) was 
mixed with 1 litre of distilled water 
 
• This was brought to boil in  a standard microwave oven 
 
• This mixture was then autoclaved at 120ºC for 15 minutes  
 
• The autoclaved mixture was then left to cool to 50ºC  
 
• 5% defibrinated horse blood was added 
 
• 25ml of this agar was then poured into each Petri dish and allowed to cool to 
room temperature   
 
2) PREPARATION OF TEST SPECIMENS  
Standard 90mm diameter sterile Petri dishes were used to culture each organism. 
The Mcfarland Scale was used to ensure that each test organism had a similar 
concentration.  This measurement uses a scale that is numbered from 1 to 10 and 
represents specific concentrations of bacteria/ml. Although not accurate, it is 
designed to be used as an estimate of the concentration of bacteria used during 
experimentation (Table 4). 
 
McFarland Scale No. Bacteria (x106/ml)
1 300 
2 600 
3 900 
4 1200 
5 1500 
  
Table-4: McFarland Turbidity Tubes 
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The McFarland Scale uses standardized tubes that are labelled 1 through 10 and 
filled with suspensions of Barium salts. Each tube approximates the turbidity of 
bacterial solutions corresponding to the McFarland Scale number. The advantage of 
this method is that no incubation time or specialized equipment is needed to 
estimate bacterial numbers. 
 
Based on a previous pilot study, McFarland Standard 3 was used as the 
concentration of each organism that was tested in this study. This corresponds to 
900 × 106/ml of bacteria. 
 
For each type of organism used (i.e. Streptococcus mutans, Streptococcus 
sanguinis, VS-1), the following sequence was followed: 
 
• A flame-sterilized loop was used to transfer the bacteria grown on an agar plate to a 
sterile test tube filled with distilled water 
 
• The bacteria was dispersed using a vortex mixer (Hedolph, Germany) for 30 seconds 
 
• The tube mixture was then compared against McFarland tube 3 to ensure that the 
turbidity matched  
 
• If the concentration was too low, more bacteria were added until the turbidity 
approximated that of McFarland tube 3 
 
• Using a Pipetman®P pipette (Gilson Inc, France), 0.5ml of the test bacteria was 
transferred from the test tube to each 90mm diameter agar containing Petri dish 
 
• This solution was spread evenly over the agar using a sterile glass spreader so as to 
ensure that an even lawn of bacterial growth would occur   
 
• The inoculated plates were then left for 3 to 5min to allow the moisture from the 
inoculum to be absorbed into the medium 
 
3) PREPARATION OF TEST TOOTHPASTES 
 
All the antibiotic disks (Munktell, Germany) used in the experiment were autoclaved 
at 121ºC for 15 minutes before being used. For each test toothpaste, and including 
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the positive control (Colgate Total® (Colgate-Palmolive, South Africa)), the following 
sequence of steps took place: 
 
• The toothpaste was squeezed from a freshly opened toothpaste tube into a sterile 
90mm Petri dish 
 
• Using a flame-sterilized forceps, 9mm sterile antibiotic disks were mixed and soaked 
into the test toothpaste.  
 
• These disks were then removed and placed into another sterile Petri dish. 
 
• The second dish which now contained the toothpaste impregnated disks, was 
labelled with a permanent marker according to the toothpaste used 
 
• This labelled dish was then allowed to dry at 37ºC in a temperature controlled room  
 
4) PREPARATION OF THE CONTROL 
 
Colgate Total® (Colgate-Palmolive, South Africa) was used as the positive control 
and a standard 9mm sterile antibiotic disk (Munktell, Germany) was used as the 
negative control.  
 
• The positive control was prepared using the same sequence of steps outlined 
in the preparation of the test toothpastes.  
 
• The negative control was autoclaved at 121ºC for 15 minutes and stored in a 
sterile Petri dish at room temperature. These disks had no contact with any of 
the test toothpastes  
 
5) PLACEMENT OF THE TEST TOOTHPASTES ONTO THE PREPARED CULTURES 
 
For each test toothpaste and including the positive control, the following sequence of 
steps took place: 
 
• Each inoculated plate was visually examined to ensure that the surface was 
dry and free of moisture 
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• A toothpaste impregnated test disk was placed onto the surface of the agar 
using a sterile forceps 
 
• The disks were tapped gently with the forceps to ensure that each disk was in 
complete contact with the surface of the agar  
 
• All disks were placed approximately the same distance from the edge of the 
plate and from each other 
 
• Four different test toothpastes were placed onto each test plate    
 
6) PLACEMENT OF THE CONTROLS ONTO THE TEST CULTURE 
 
Three culture plates were used for the controls, one for each bacterial species 
tested. Two positive controls that consisted of Colgate Total® (Colgate-Palmolive, 
South Africa) and two negative controls that consisted of 9mm sterile antibiotic disks 
(Munktell, Germany) were placed onto each of the three culture plates. This was 
carried out in the same way as the process outlined in the placement of the test 
toothpastes onto the cultures. 
 
7) INCUBATION 
 
All test plates including the control plates were placed into microaerophilic pots and 
incubated at 37ºC in a temperature controlled room for 24 hours.  
 
4.5.  DATA COLLECTION 
 
After incubation for 24 hours, zones of inhibition were measured around the test 
disks. This time period was chosen because previous studies have indicated that no 
significant increase of zone size is observable after 24 hours (Lee 2004). The 
inhibition zones are circular bacteria-free areas around the test disk on the culture 
plate. They indicate areas where no bacterial growth has taken place. Viewed 
against a black background and illuminated with reflected light, each diameter of the 
zone was measured in millimetres using a venire calliper to the nearest whole 
millimetre. All measurements were conducted by the same person.  
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4.6.  DATA PROCESSING AND ANALYSIS: 
 
The results were compared and analyzed using SPSS13 for Windows®.  
 
For each toothpaste type, the mean and standard deviation of the diameters of 
zones of inhibition were calculated. The following statistical tests were applied; 
 
• one-way analysis of variance, or ANOVA and  
 
• a multiple comparison Tukey’s test to determine the significance of 
differences among the means at the significance level of p = 0.5. 
 
4.7.  ETHICS: 
 
The study was purely laboratory based and required no human tissue or sampling. 
Any significant results will be submitted for publication in a relevant dental or medical 
journal. 
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CHAPTER 5 
RESULTS 
 
5.1. DESCRIPTIVE ANALYSIS 
 
After 24 hours of incubation, all four test toothpastes displayed observable zones of 
inhibition (Table 5). The positive control, Colgate Total® (Colgate-Palmolive, South 
Africa) produced inhibition zones for all three microorganisms cultured (Strep 
mutans, Strep sanguinis, and VS-1 ) (Fig 3), whereas the negative control, a sterile 
antibiotic disk (Munktell, Germany), produced no observable inhibitory effect for any 
of the bacteria (Fig 4).  
 
               
   Fig 3: Colgate Total®    Fig 4: Sterile Disk 
 
 
Only three of the test toothpastes i.e. Colgate Herbal® (Colgate-Palmolive Company, 
South Africa), Aquafresh Herbal® (GlaxoSmithKline, South Africa)   and Dentazyme 
Herbal® (Amka Products, London), produced zones of inhibition against all the 
microorganisms (S.mutans, S. sanguinis and VS-1). Nature Fresh (antimicrobial)® 
(Nature Fresh, Constantia, South Africa) only showed inhibitory zones for viridans 
Streptococci.  
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Toothpastes and Controls S. mutans S. sanguinis         VS-1 
Sterile Disk (Negative Control ) 2 2 2 
Colgate Total (Positive Control ) 1 1 1 
Nature Fresh 2 2 1 
Colgate Herbal 1 1 1 
Dentazyme Herbal 1 1 1 
Aquafresh Herbal 1 1 1 
        
1 = inhibition observed       
2 = no inhibition observed       
 
 
  Table 5: The presence of observable inhibition for the various toothpastes  
 
5.2. STATISTICAL ANALYSIS 
All the toothpastes produced different sized inhibition zones (Fig 5). Dentazyme 
Herbal® showed the largest zone of inhibition and Nature Fresh (antimicrobial)®, the 
smallest.  
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Fig 5 : Mean diameter ( in millimetres ) of zones of inhibition 
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Analysis of variance (ANOVA), showed a significant difference in sizes of these 
zones when the various toothpastes were compared to each other  (p<0.05) (Table 
6).  
 
           Bacteria             Groups             Significance 
S. mutans Between groups             p= 0.000 
 Within groups             p= 0.000 
S. sanguinis Between groups             p= 0.000      
 Within groups             p= 0.000      
VS-1 Between groups             p= 0.000     
 Within groups             p= 0.000     
 
      Table 6: Analysis Of Variance  
 
Tukey’s multiple comparison test was used to determine which of the zone sizes 
produced by the various toothpastes were statistically different from each other for 
each of the cultures tested. The following results were obtained: 
 
For S. mutans: 
 
        Table 7: Tukeys test for S. mutans 
 
The differences in inhibition zones produced by the various toothpastes were 
statically significant except for when Aquafresh Herbal® was compared to Colgate 
Total®.  Dentazyme Herbal® was significantly stronger than any of the other 
  
Dentazyme 
Herbal 
Aquafresh 
Herbal 
Nature 
Fresh 
Colgate 
Herbal 
Colgate Total   
   (Control) 
Dentazyme Herbal      p = 0.000 p = 0.000 p = 0.000 p = 0.000 
Aquafresh Herbal     p = 0.000 p = 0.038 p = 0.671 
Nature Fresh       p = 0.000 p = 0.000 
Colgate Herbal         p = 0.001 
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toothpastes (including the control, Colgate Total®) in its ability to inhibit the growth of 
S. mutans.  
 
For S. sanguinis: 
  
     Table 8: Tukeys test for S. sanguinis 
 
For S. sanguinis, the zones of inhibition produced by Aquafresh Herbal®, Colgate 
Herbal® and Colgate Total®, were not significantly different from each other. 
Dentazyme Herbal® was significantly stronger than any of the other toothpastes in 
inhibiting the growth of S. sanguinis.  
 
For VS-1: 
   
            Table 9: Tukeys test for VS-1 
 
Dentazyme Herbal®, Aquafresh Herbal® and Colgate Total® showed no significant 
difference between the toothpastes in their ability to inhibit the growth of VS-1.  
  
Dentazyme 
Herbal 
Aquafresh 
Herbal 
Nature 
Fresh 
Colgate 
Herbal Colgate Total 
Dentazyme Herbal     P = 0.000 p = 0.000 p = 0.000 p = 0.000 
Aquafresh Herbal     p = 0.000 p = 0.972 p = 0.062 
Nature Fresh       p = 0.000 p = 0.000 
Colgate Herbal         p = 0.232 
  
Dentazyme 
Herbal 
Aquafresh 
Herbal 
Nature 
Fresh 
Colgate 
Herbal Colgate Total 
Dentazyme Herbal     p = 0.785 p = 0.000 p = 0.000    p = 0.869 
Aquafresh Herbal     p = 0.000      0.006    p = 1.000 
Nature Fresh            0.639    p = 0.000 
Colgate Herbal            p = 0.004 
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Nature Fresh® and Colgate Herbal® were also not significantly different from each 
other in their ability to inhibit its growth.  
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CHAPTER 6 
DISCUSSION 
 
Periodontal disease is a bacterial related infection that results in the progressive 
destruction of oral soft and hard tissue (Beck and Arbes 2002). The clinical 
management of the condition is directed towards the suppression or elimination of 
the offending bacteria. Not only are these specific bacteria being targeted, but the 
nature of their growth (a biofilm) has recently also been established as a potential 
therapeutic target (Marsh 2005). As such, the use of local and systemic antibiotics to 
treat periodontal disease is increasing and with it, a proportional increase in the 
amount of resistant oral pathogens is being reported. The safe elimination of plaque 
associated bacteria without the risk of developing antibiotic resistant strains may 
therefore offer some clinical benefit in the prevention and management of 
periodontal disease.   
 
Recently triclosan has been added to toothpaste as an antimicrobial agent (Cullinan 
et al 2003). However because unlike chlorhexidine, it has no ionic attachment to the 
tooth surface, it requires the presence of a copolymer to adhere to the tissue.  This 
disadvantage together with the emergence of triclosan-resistant bacteria has 
encouraged researchers to search for alternative antimicrobial sources (Davies 
2004).    
 
One of these sources includes the wide variety of herbs and herbal derived products 
that are currently marketed for therapeutic use. Many of these herbs have 
established antibiotic properties that have yielded positive results against a host of 
microrganisms including a variety of oral bacteria.       
 
Relatively few studies in the literature have directly compared the effect of herbal 
based toothpastes on plaque associated bacteria. Most previous studies have tested 
individual herbal derivatives on oral pathogens or have used herbal based 
mouthrinses as their test material (Koo et al 2000, Groppo et al 2002). The 
substantivity of toothpaste makes it an ideal mechanism for delivering antimicrobials 
to the oral cavity, and was therefore chosen as the dentifrice of choice for this study. 
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The aim of the present study was to determine whether there was any significant 
difference in the antimicrobial activity produced by certain herbal based toothpastes. 
S. mutans, S. sanguinis and a non-specific species of α-heamolyitic viridans 
streptococci (VS-1) were selected as the test bacteria because they have been 
implicated in primary plaque colonization.  These bacteria are the pioneer species in 
plaque formation and their presence alters the structure of the plaque to favour the 
growth of anaerobic organisms. S. mutans modifies gene expression and protein 
formation whereas S. sanguinis is essential for co-aggregation and epithelial cell 
attachment. Elimination or reduction of these species may therefore prevent the 
formation of an environment that promotes the growth of the so called 
“periodontopathogens”. 
 
The in-vitro diffusion method was used because it displayed a relatively direct means 
of measuring the antimicrobial strength of each product i.e. the product producing 
the largest zone of inhibition, had the strongest antimicrobial properties.   
 
The results of the present study indicate that all of the test toothpastes have some 
degree of antimicrobial ability. Dentazyme Herbal® produced the largest zones of 
inhibition and therefore had the strongest antimicrobial effect, of all the toothpastes 
tested. This was irrespective of the bacterial culture that was used. It routinely 
produced stronger inhibition than Colgate Total®, a toothpaste that contained a 
known antimicrobial ingredient. The antibacterial properties of Dentazyme Herbal® 
may be attributed to several factors including two significant ingredients that it 
contains .i.e. tea tree oil and eugenol. Dentazyme Herbal® and Colgate Herbal® are 
the only products used in the study that contain both these constituents, both of 
which have documented anti-bacterial activity. When looking at the results however, 
it is clearly seen that Dentazyme Herbal® has significantly stronger antimicrobial 
potential as compared to Colgate Herbal®. Therefore the antimicrobial effect cannot 
only be accounted for by the presence of these two ingredients and other 
contributing factors must be taken into account.  
 
Aquafresh Herbal® was as strong as Colgate Total® in inhibiting the growth of S. 
mutans, S. sanguinis and VS-1. Colgate Herbal® however, had a minimal inhibitory 
effect against most of the bacteria tested, producing inhibition zones that were 
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consistently smaller than that produced by Dentazyme Herbal®, Aquafresh Herbal® 
and Colgate Total®. 
 
Nature Fresh® is the only non fluoride containing toothpaste that was used in the 
study. The product promotes itself as being purely herbal and strongly antimicrobial. 
In the present study, it was significantly weaker than most of the other toothpastes in 
its ability to inhibit bacterial growth. It displayed no inhibitory effect for both S.mutans 
and S. sanguinis and only produced limited ability to inhibit the growth of VS-1. 
Although limitations are associated with the present study, the effectiveness of 
Nature Fresh® as a potential therapeutic agent in the prevention or management of 
periodontal disease therefore needs to be questioned.  The toothpaste was also 
500% more expensive than any of the other toothpastes used.   
   
Colgate Total® consistently showed the ability to inhibit the growth of all of the 
bacteria tested. This was similar to the results published by previous studies (Lee et 
al 2004). This inhibition was likely to be as a consequence of the inclusion of 
triclosan in the toothpaste. Triclosan had previously shown excellent results in its 
antimicrobial potential, being effective in both laboratory and clinical based research 
(Davies 2004). Colgate Total® is currently one of the few toothpastes that contains 
triclosan and it was therefore chosen as the control for this experiment.    The fact 
that Dentazyme Herbal® displayed a stronger antimicrobial effect when compared to 
Colgate Total® was an unexpected finding. This result however has therapeutic 
consequences since previous studies have shown that incorporating antimicrobials 
into toothpastes may have some clinical benefit in the management of periodontal 
disease (Cullinan et al 2003).  
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CHAPTER 7 
LIMITATIONS 
 
There are some important limitations to the present study. 
 
Although the study shows significant results for the toothpastes tested, these results 
need to be interpreted with caution.   
 
One such factor is the presence of fluoride, a chemical with known antimicrobial 
activity. Except Nature Fresh (antimicrobial)®, all the toothpastes tested, contained 
fluoride. Colgate Total®, Aquafresh Herbal® and Dentazyme Herbal® contained 
sodium fluoride whereas Colgate Herbal® contained sodium monoflourophosphate. 
The concentration of fluoride was only indicated on the Colgate® products and was 
1.1% for Colgate Herbal® verses 0.3% for Colgate Total®. Whether the difference in 
the type of fluoride or the variation in concentration affected the antimicrobial activity 
of the toothpaste, requires further investigation.  
 
Another confounding factor was the variety and concentration of herbs or herbal 
derivatives contained in the various toothpastes. All of the toothpastes contained 
more than one herbal derivative but none of the products mentioned the 
concentration of these ingredients. Although the herbal ingredients may be effective 
individually, their combination together with the other ingredients such as 
surfactants, colourants, flavourants and humectants, may affect their ability to inhibit 
bacterial growth.  
 
Because all the toothpastes were put onto sterile disks and allowed to diffuse into 
the agar, their relative rates of diffusion must be taken into account. This rate of 
diffusion, which may be dependent on the individual constituents of the toothpaste, 
may vary according to manufacturer. This may influence the penetration of the agar 
and therefore the effectiveness of the antimicrobial activity (Lee et al 2004). 
 
Because the study was laboratory based, the substantivity of the toothpastes was 
not taken into account. The test toothpastes used in the study were used at full 
concentration and therefore might not have the same effect if used clinically. 
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CHAPTER 8 
CONCLUSIONS 
 
All the herbal toothpastes tested in this study displayed varying degrees of 
antimicrobial activity against the 3 primary plaque colonizers tested. Their ability to 
inhibit bacterial growth was significantly different. 
 
Dentazyme Herbal® consistently showed the strongest ability to inhibit bacterial 
growth for all the bacteria tested. It was stronger than the control toothpaste in most 
cases.  The reason for this particular toothpastes’ antimicrobial properties cannot be 
explained from the present study and further research is required to determine the 
cause of it antimicrobial effect. 
 
Although the study had significant limitations, the ability of a herbal toothpaste to 
inhibit the growth of bacteria associated with plaque colonization has several 
potential therapeutic benefits. It may obviate the development of antibiotic-resistant 
plaque bacteria or may potentially be used to supplement triclosan in the inhibition of 
plaque growth.  This inhibition of growth of the plaque biofilm may ultimately prevent 
the development of a biofilm that has the potential to destroy hard and soft tissue. 
 
Further research is required to determine whether the antimicrobial properties of 
these herbal toothpastes have any clinical relevance.   
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